Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -0.44% 56.75p 56.00p 57.50p 57.00p 56.75p 57.00p 124,268.00 09:53:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -6.1 -5.1 - 68.46

Futura Medical Share Discussion Threads

Showing 14076 to 14099 of 14100 messages
Chat Pages: 564  563  562  561  560  559  558  557  556  555  554  553  Older
DateSubjectAuthorDiscuss
18/1/2017
18:29
I suspect big news soon, especially when he is gifting shares to his kids. Well played sir...
bigdeka1972
18/1/2017
15:29
EU extended shelf life approval for the erectogenic condom.Further condom launches.More pain gel licensing agreements.
j777j
18/1/2017
14:14
Am expecting an another out licensing deal for topical pain relief before results.
greedfear
18/1/2017
13:28
Prelim. FY results early March mtb4
mikethebike4
18/1/2017
13:08
Has anyone got any thoughts on what the next bit of news will be?
tackems
18/1/2017
08:27
http://kabey-pharma.com/index.php/manex/condom_range
lbo
12/1/2017
18:58
I think you will find they used the sale to pay for the shares so effectively took the remaining ones for free
dave444
12/1/2017
17:15
Yes does inspire confidence.
montyhedge
12/1/2017
16:13
Share options At 31 December 2015, the number of ordinary shares of 0.2 pence each subject to share options granted under the Company’s Approved and Unapproved Share Option Schemes were: Exercise Price per Share At 1 January 2015 Grants During Year Options Lapsed At 31 December 2015 Exercise Period Pence Number Number Number Number 1 August 2011 - 31 July 2016 24.25 314,279 - - 314,279 1 August 2012 - 31 July 2017 40.50 662,962 - (180,000) 482,962 1 October 2013 - 30 September 2018 56.50 827,500 - (200,000) 627,500 1 October 2014 - 30 September 2019 61.50 860,000 - (200,000) 660,000 1 October 2015 - 30 September 2020 71.50 950,000 - (200,000) 750,000 1 October 2016 - 30 September 2021 51.75 1,240,000 - (200,000) 1,040,000 1 October 2017 - 30 September 2022 30.00 - 1,110,000 - 1,110,000 4,854,741 1,110,000 (980,000) 4,984,741 So 382k of 482k available were exercised. director emoluments & salaries are shown, so I retract my previous post.
sportbilly1976
12/1/2017
16:07
SportsThat's ok if that's the case, the amounts are not massive.
montyhedge
12/1/2017
16:06
Don't like that when directors sell, when we are all waiting for the next rns to come along.
montyhedge
12/1/2017
16:05
Are they not paid shares in lieu of salary?
sportbilly1976
12/1/2017
16:00
Surprised they cashed inWhat confidence does that give shareholders ?
jailbird
12/1/2017
15:09
RNS - a bit of option cashing in: James Barder, Chief Executive, exercised options over 250,000 ordinary shares, of which he has sold 210,000 Ordinary Shares in the Company at a price of 55.172 pence per share. Derek Martin, Finance Director, exercised options over 100,000 Ordinary Shares in the Company which he has sold at a price of 55.172 pence per share. Tim Holland, PDMR, exercised options over 2,962 Ordinary Shares in the Company which he has sold at an average price of 55.172 pence per share.
sportbilly1976
12/1/2017
14:46
mmm, a few interesting trades - hopefully forthcoming rns' may clear them up 1.9mln at 55.75p 2x 800k also at 55.75 almost a further half million around 56p might explain the stagnation around these level recently...
sportbilly1976
12/1/2017
14:31
Big volume today
jailbird
12/1/2017
12:11
You would think so wouldn't you but given past performance cannot take anything for granted However if I had any money to spare I would buy some more at this juncture mtb4
mikethebike4
12/1/2017
10:45
yup totally agree ... think the point is that given progress at tail end of last year would expect to start flowing sooner rather than later.
meganxmas
12/1/2017
10:28
It's all very well having all these agreements but what we want is income from them ! mtb4
mikethebike4
12/1/2017
10:01
We have partnerships with leading pharmaceutical and healthcare groups.Ansell Limited?Futura has an exclusive worldwide agreement with Ansell Limited for the distribution rights to our topical product for premature ejaculation and has an exclusive licensing agreement for the distribution rights to our condom product CSD500 in China. Ansell is a world leader in providing superior health and safety protection solutions that advance human wellbeing.www.ansell.comBizzy Diamond Heathcare?Bizzy Diamond Healthcare is a Dutch company, founded in 2003 by Ineke Zijderveld. Bizzy Diamond Healthcare has 18 years' experience in the development, production and marketing of condoms, lubricants and related products. Bizzy Diamond Healthcare have the distribution rights to our condom product CSD500 in the Netherlands and Belgium.www.bizzydiamond.comChurch and Dwight Co., Inc.?Futura has an exclusive agreement with Church and Dwight Co., Inc. for the distribution rights to our condom product CSD500 in North America and in a number of key European territories. Church and Dwight's condom brand Trojan® is the number one condom brand in North America.www.churchdwight.comKabey Pharmaceuticals?Futura has an exclusive licensing agreement with Kabey Pharmaceuticals, a Middle Eastern healthcare company, for the distribution rights to our condom product CSD500 for 15 countries in the Middle East and North Africa region.www.kabey-pharma.comKwang Dong Pharmaceutical?Futura has an exclusive licensing agreement with Kwang Dong Pharmaceutical, an established South Korean healthcare company, for the distribution rights to our condom product CSD500 in South Korea.www.eng.ekdp.comMilsing d.o.o.?Futura has an exclusive licensing agreement with Milsing d.o.o. for the distribution rights to our condom product CSD500 in seven territories in South East Europe, including Croatia and Serbia. Milsing is a leading company in the over the counter Drug and Food supplement market in South East Europe.www.milsing.comRFSU AB?Futura has an exclusive licensing agreement with RFSU AB for the distribution rights to our condom product CSD500 in Sweden, Norway, Finland and Denmark. RFSU AB is an independent not-for-profit organisation which is the market leader in Scandinavia for condoms.www.rfsu.seThornton & Ross?Futura has an exclusive licensing agreement with Thornton & Ross, the UK subsidiary of STADA Arzneimittel AG ("STADA") for the distribution rights to our pain relief gel TPR100 in the UK. Thornton & Ross is one of the largest consumer health companies in the UK.www.thorntonandross.co.ukwww.stada.comTTK Protective Devices Limited?Futura has an exclusive licensing agreement with TTK Protective Devices Limited (TTK) for the distribution rights to our condom product CSD500 in India. Futura also has a manufacturing agreement with TTK for worldwide supply of CSD500. TTK is a pioneer in the condom business and part of the substantial Indian conglomerate TTK Group.www.skorecondoms.co
meganxmas
12/1/2017
09:57
https://www.google.fr/url?sa=t&source=web&rct=j&url=http://www.futuramedical.com/content/partners/our_partners.asp&ved=0ahUKEwiShtilqrzRAhUOkRQKHfW7DYgQFggdMAE&usg=AFQjCNHE64E7tk-FAUgHkhObpWG2TLnH2wdont know if this works but if not look at their website. their strategy and partners for the condom looks spot on. now that shelf life sorted expect lots of positives going forward not least the gradual but vast long term increase in royalties. of course any investor will have read this stuff already !!!
meganxmas
12/1/2017
09:36
Surely Church & Dwight will launch THE condom this year.
greedfear
11/1/2017
17:18
'Durex may dominate global sales, with about 30 per cent, but it is a relative tiddler in the US, where Trojan – owned by Church & Dwight – has a 69 per cent share.'
deltar
11/1/2017
14:05
buy trades at 56.5p
sportbilly1976
Chat Pages: 564  563  562  561  560  559  558  557  556  555  554  553  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170119 00:18:52